Bioequivalence of Different Formulations of Zonisamide Oral Suspensions: A Short Review

Bioequivalence and switchability of generic antiseizure medications (ASMs): A re‐appraisal based on analysis of generic ASM products approved in Europe

(2021) Reem Odi et al.   EPILEPSIA

Narrow Therapeutic Index drugs: clinical pharmacology perspective

(2021) Sam Habet   JOURNAL OF PHARMACY AND PHARMACOLOGY

Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs

(2021) Anthony G Marson et al.   HEALTH TECHNOLOGY ASSESSMENT

Evaluation of zonisamide for the treatment of focal epilepsy: a review of pharmacokinetics, clinical efficacy and adverse effects

(2020) Slobodan M. Janković   Expert Opinion on Drug Metabolism & Toxicology

Has the time come to employ population and individual bioequivalence for the evaluation of generics?

(2020) Francis Micheal et al.   CURRENT DRUG METABOLISM

Relative bioavailability of an extemporaneously prepared aprepitant oral suspension in healthy adults

(2019) Priya Patel et al.   JOURNAL OF ONCOLOGY PHARMACY PRACTICE

The Impact of the Pharmacist’s Intervention on Patient Education and Dosing of Suspensions

(2018) Emily C. Darst et al.   AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION

Feasibility of amlodipine besylate, chloroquine phosphate, dapsone, phenytoin, pyridoxine hydrochloride, sulfadiazine, sulfasalazine, tetracycline hydrochloride, trimethoprim and zonisamide in SyrSpend ® SF PH4 oral suspensions

(2016) Anderson O. Ferreira et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Stability of zonisamide in extemporaneously compounded oral suspensions

(2009) C. V. Abobo et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Bioequivalence of zonisamide orally dispersible tablet and immediate-release capsule formulations: Results from two open-label, randomized-sequence, single-dose, two-period, two-treatment crossover studies in healthy male volunteers

(2009) Rob van Maanen et al.   CLINICAL THERAPEUTICS

Zonisamide in children and young adults with refractory epilepsy: An open label, multicenter Italian study

(2008) Giangennaro Coppola et al.   EPILEPSY RESEARCH